As of 2024-10-03, the Relative Valuation of Meridian Bioscience Inc (VIVO) is 39.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.97 USD, the upside of Meridian Bioscience Inc based on Relative Valuation is 15.8%.
The range of the Relative Valuation is 34.85 - 40.31 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.1x - 41.1x | 39.8x |
| Forward P/E multiples | 30.8x - 35.2x | 35.2x |
| Fair Price | 34.85 - 40.31 | 39.35 |
| Upside | 2.6% - 18.7% | 15.8% |
| Date | P/E |